SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Merck to buy back Riverside plant for key API supply

11-Aug-2010 - US drugmaker Merck & Co has announced plans to reacquire a Pennsylvania manufacturing plant to guarantee supply of key active pharmaceutical ingredient (API).

Endo to buy Penwest for Opana ER tech

10-Aug-2010 - Endo Pharmaceuticals will pay $168m (€127.7m) for drug delivery tech and formulations firm Penwest Pharmaceuticals in bid to expand pain portfolio.

US patients call for Fabrazyme patent break; Are you watching Sanofi?

03-Aug-2010 - Calls for US government to break Genzyme’s Fabrazyme patents accompany more speculation that French drugmaker Sanofi Aventis is in takeover talks.

Bilcare to boost EU and US access with €100m Ineos Films buy

03-Aug-2010 - Bilcare to buy Ineos’ rigid polymer films business for €100m ($132m) to improve access to pharmaceutical packaging customers worldwide.

News in brief

Heinkel boosts separation offering with Comber buy

02-Aug-2010 - Heinkel expands pharmaceutical filtering and drying systems business with acquisition of Italian equipment maker Comber.

Guest article

Pharma consolidation and the downstream impact on CROs

29-Jul-2010 - Significant biopharm consolidation has played a key role in reshaping the drug development sector. Viq Pervaaz, senior vice president at Aon Consulting, discusses the changes and how they will impact...

Colorcon builds coating biz with Indian buy

27-Jul-2010 - Colorcon will buy Indian group Pharmaceuitcal Coatings to expand both its tablet film coating business and presence in “rapidly growing” pharmaceutical market.

Constantia buys Tobepal from Amcor

22-Jul-2010 - Austria’s Constantia Packaging will pay Amcor €92m ($118m) for its Spanish Tobepal flexible packaging business.

Merck Millipore launched after $7bn takover

19-Jul-2010 - Germany’s Merck KGaA has completed its $7bn (€b5.2n) acquisition of Millipore, unveiling plans to target “high-growth, high-margin” bio-research and bio-production markets.

Guest article

M&A processes, pitfalls and keys to success

15-Jul-2010 - M&A can help revitalize firms but failure to properly integrate the companies can create an inefficient, demoralized business. In this article, Viq Pervaaz, senior vice president at Aon Consulting, takes...

Merck to close eight production facilities, eight R&D labs

12-Jul-2010 - Merck & Co is to close or sell eight manufacturing plants and a further eight R&D laboratories as part of efforts to cuts its workforce by 15 per cent.

Sanofi said to be planning $20bn acquisition in US

05-Jul-2010 - Rumour has it that French drug giant Sanofi Aventis is planning to make a $20bn (€16bn) acquisition in the US with speculation that biotechs like Allergan, Biogen Idec and Genzyme...

Abbott exploring sale of vaccines unit

05-Jul-2010 - Abbott Laboratories has confirmed it is considering the sale of the vaccines unit it gained with the €4.5bn ($6.2bn) acquisition of Solvay Pharmaceuticals in February .

Alembic to demerge pharma business

30-Jun-2010 - India’s oldest pharmaceutical company Alembic went one step closer to the biggest restructuring in its history as its board approved the demerging of its main pharmaceutical business into a separate...

Sosei buys Activus Pharma and drug delivery technology

29-Jun-2010 - Sosei has revealed its intention to acquire Activus Pharma in a deal which allows the Japan-based firm to get their hands on Activus' nanoparticle drug formulation tools, a technology that’s...

Gilead buys a $120m ticket for protein kinase research role

28-Jun-2010 - A deal to broaden Gilead’s research expertise into protein kinase biology has been finalised with the $120m acquisition of CGI Pharmaceuticals, in a deal that compliments its comprehensive selection of...

News in brief

Biovail and Valeant to merge

23-Jun-2010 - Canada’s Biovail plans to buy Valeant Pharmaceuticals to strengthen US position in specialty CNS, dermatology and generics markets.

Minapharm buys CMO ProBioGen for €30.4m

17-Jun-2010 - Egypt-based Minapharm has acquired 95 per cent of CMO ProBioGen for a possible total of €30.4m ($37.6m).

Interactive Quiz

US industry quiz – how much do you know about H1 2010?

11-Jun-2010 - Know your Lilly from your Lonza? Then test your industry knowledge against colleagues, peers and our community of readers by participating in our exclusive map-based quiz.

Surya raising funds to invest in production capacity

02-Jun-2010 - India-based Surya Pharmaceuticals is planning to raise Rs 500 crore ($100m) to fund construction of an active pharmaceutical ingredient (API) production plant, according to local media reports.

Financial climate better for potential delivery unit sale, says Elan

01-Jun-2010 - Irish pharmaceutical company Elan says most potential investors are positive about proposal to spin-off drug delivery unit.

Adcock plans expansions & acquisitions to drive growth

26-May-2010 - Adcock Ingram recorded an 11 per cent rise in profit in the first half of 2010 and is looking to continue this upwards trend through manufacturing expansions, plus local and overseas acquisitions.

Invida buys in Indonesia to gain local production presence

24-May-2010 - Invida has acquired a stake in Indonesia-based MUGI, giving it the local manufacturing presence needed to offer partners access to “a vast untapped market”.

News in brief

Is Sanofi looking at Piramal again?

19-May-2010 - Rumours have resurfaced that Indian generics firm Piramal Healthcare is in talks with Sanofi-Aventis and Pfizer about a potential takeover.

Pfizer to close 8 sites, cut ops at 6 more; 6,000 jobs to go

19-May-2010 - Pfizer plans to close eight manufacturing sites and reduce operations at a further six by the end of 2015, leading to 6,000 job losses, as part of its reorganisation after acquiring Wyeth.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...